Guggenheim Initiates Coverage On Exact Sciences with Buy Rating, Announces Price Target of $90
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Subbu Nambi has initiated coverage on Exact Sciences (NASDAQ:EXAS) with a Buy rating and set a price target of $90.
December 14, 2023 | 11:28 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exact Sciences receives a Buy rating from Guggenheim with a price target of $90, indicating a positive outlook from the analyst.
Analyst ratings, especially from reputable firms like Guggenheim, can significantly influence investor sentiment and stock prices in the short term. A Buy rating combined with a high price target suggests a strong positive outlook for Exact Sciences, which could lead to an increase in stock price as investors react to the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100